Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer

Nai Jung Chiang, Jang Yang Chang, Yan Shen Shan, Li Tzong Chen

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences